EichorEICHOR
Location: Tilburg Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Tilburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The Effects of a Dynamic Arm Support in Daily Life
Phase N/A · Focal Meditech BV (their clients in their home situation) · Hasselt University · NCT07121075REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · Elisabeth-TweeSteden Ziekenhuis Tilburg · Sint Maartenskliniek · NCT07160231A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Elisabeth-TweeSteden Ziekenhuis (ETZ) · Alimentiv Inc. · NCT07363044Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · ETZ Elisabeth · Eli Lilly and Company · NCT06890598A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · St. Elisabeth Ziekenhuis · Janssen Research & Development, LLC · NCT07499232A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Phase 2 · St. Antonius Ziekenhuis · Takeda · NCT06764615Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · ETZ Elisabeth · Daiichi Sankyo · NCT06731478The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · Elisabeth-TweeSteden Ziekenhuis · Alzheimercentrum Amsterdam · NCT07680335DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass
NA · Elisabeth-Tweesteden Hospital · St. Antonius Hospital · NCT04894838Physical Exercise for Patients With Head and Neck Cancer
NA · Instituut Verbeeten · Institute Verbeeten · NCT05988060A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · ETZ Elisabeth · Eli Lilly and Company · NCT06119581A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Etz Elisabeth · Daiichi Sankyo · NCT06203210A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induce
Phase N/A · ETZ · Rijnstate Hospital · NCT07304401DIGITAL-KNEE Study: Adequately Diagnosing Total Knee Arthroplasty Loosening by Evaluating the AtMoves Knee System in a R
NA · Elisabeth-TweeSteden Ziekenhuis · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06839807Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study
NA · GGz Breburg · Maastricht University · NCT05812950Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Phase 4 · Elisabeth Tweesteden Ziekenhus · Leiden University Medical Center · NCT06172010Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · ETZ Elisabeth-Internal Medicine ( Site 1160) · Merck Sharp & Dohme LLC · NCT06136624Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
NA · Elisabeth-Tweesteden Hospital · Next Biomedical Co., Ltd. · NCT06930677A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Phase 2 · Investigational Site Number : 5280001 · Sanofi · NCT06637631Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction
Phase 2 · Elisabeth Tweesteden Ziekenhuis · Erasmus Medical Center · NCT06161818Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Phase N/A · Stichting Elisabeth-Tweesteden Ziekenhuis · W.L.Gore & Associates · NCT06218875Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Phase 2 · ETZ Elisabeth · Abivax S.A. · NCT06456593Psychoeducation for Older Adults With Autism
NA · GGz Breburg PersonaCura · Tilburg University · NCT06127472Prospective Bladder Cancer Infrastructure (ProBCI)
Phase N/A · Elisabeth-TweeSteden Ziekenhuis · Prospective Bladder Cancer Infrastructure Foundation · NCT04503577LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · Elisabeth-TweeSteden Ziekenhuis · Eli Lilly and Company · NCT07186101Prospective Data Collection Initiative on Colorectal Cancer
Phase N/A · Elisabeth-TweeSteden Ziekenhuis · Dutch Colorectal Cancer Group · NCT02070146A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat
Phase 2/Phase 3 · Local Institution - 0216 · Bristol-Myers Squibb · NCT07221357Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Phase 3 · ETZ Tilburg - ETZ - St. Elisabethziekenhuis · European Organisation for Research and Treatment of Cancer - · NCT05904119
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.